MARKET

AURX

AURX

Nuo Therapeutics
OTCMQB
1.010
NaN%
Closed 09:30 07/02 EDT
OPEN
--
PREV CLOSE
1.010
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
3.100
52 WEEK LOW
0.905
MARKET CAP
48.89M
P/E (TTM)
-20.2000
1D
5D
1M
3M
1Y
5Y
1D
Nuo Therapeutics Expands Secured Debt Facility and Warrants
TipRanks · 06/03 10:56
Nuo Therapeutics GAAP EPS of -$0.01, revenue of $1.3M
Seeking Alpha · 05/14 21:40
Press Release: Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
Dow Jones · 05/14 21:24
NUO THERAPEUTICS ANNOUNCES FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Reuters · 05/14 21:15
Nuo Therapeutics Q1 net loss narrows to $618,000; revenue more than doubles to $1.3 million
PUBT · 05/14 21:02
Roth MKM Reaffirms Their Buy Rating on Nuo Therapeutics (AURX)
TipRanks · 04/14 21:15
Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Nuo Therapeutics (AURX)
TipRanks · 04/02 13:10
Nuo Therapeutics Secures New Debt Financing and Warrants
TipRanks · 01/26 21:49
More
About AURX
Nuo Therapeutics, Inc. is a commercial stage medical device company. The Company is focused on developing and marketing products for chronic wound care primarily within the United States. It has commercialized cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company's product, Aurix, is a biodynamic hematogel that uses a patient’s own platelets and plasma as a catalyst for healing. Its commercial offering consists of a point of care technology for the separation of autologous blood to produce a platelet-based therapy for use in the chronic wound care market. The Aurix System produces a platelet-rich plasma (PRP) gel at the point of care using the patient’s own platelets and plasma sourced from a small draw of peripheral blood. The Aurix PRP comprises a natural, endogenous complement of protein and non-protein signal molecules that are believed to contribute to effective healing.

Webull offers Nuo Therapeutics Inc stock information, including OTCMQB: AURX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AURX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AURX stock methods without spending real money on the virtual paper trading platform.